COVID-19
view channel
view channel
view channel
view channel
view channel
view channel
view channel
Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyLab Tech.BioResearchIndustry News
Events
- Biomarker Panel Evaluated for Primary Hyperoxaluria Patients
- HPLC Method Developed for Vitamin B6 Quantitation
- Elevated Vitamin-B12 Level Lowers Risk of Parkinson’s Disease Dementia
- Novel Glycoprotein Biomarker Evaluated for Liver Fibrosis
- C-Reactive Protein Predicts Neurological Outcomes of Subarachnoid Hemorrhage Patients
- Germline Risk Variants Found in Prostate Cancer Patients
- Non-Invasive Blood Assay Can Detect Early Colorectal Cancer
- New Blood Test Can Determine When an Individual Was Exposed to a Pathogenic Microorganism
- Rare Kidney Cancer Marked by Molecular Features
- Higher Concentrations of COVID-19 Receptor Protein Found in Men’s Plasma
- Microcytosis Is a Risk Marker of Cancer in Primary Care
- Lupus Anticoagulant Prolongs Activated Partial-Thromboplastin Time in COVID-19
- Blood Clotting Causes Significant Mortality in COVID-19 Patients
- Physiological Mechanisms Underlying Prevalent Pediatric Leukemia Discovered
- Complete Blood Count Predicts Asymptomatic Preterm Birth
- A Series of Sensitive and Specific DNA-Based Assays Detects and Differentiates Salmonella Serotypes
- Giemsa Stain Outperforms Urease Test for Helicobacter Pylori Diagnosis
- Deep Throat SARS-CoV-2 Viral Load Ascertained in Saliva Samples
- Novel Rapid Test Developed for Detecting Carbapenemase
- Novel Nanofluidic Device Traps and Concentrates Pathogenic Bacteria
- Esophageal Cancer Precursor Detected by Electronic Nose Device
- Analyzer Platform for Simultaneous Detection of Multiple Sexually Transmitted Infections Is Now CE-marked
- New Chemistry Analyzer Completes Ortho Clinical Diagnostics’ Catalogue of VITROS XT Solutions
- Optical Biosensor Reduces Time for Sepsis Diagnosis
- Global Blood Glucose Monitoring Devices Market to Reach USD 13 Billion by 2023
- Global ELISA Kits Market to Surpass USD 418.5 Billion by 2025
- Thermo Fisher Scientific to Acquire QIAGEN N.V.
- New AI System Performs as Well as Expert Pathologists in Identifying Prostate Cancer
- Quest Diagnostics Acquires Blueprint Genetics
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
COVID-19
- Biomarker Panel Evaluated for Primary Hyperoxaluria Patients
- HPLC Method Developed for Vitamin B6 Quantitation
- Elevated Vitamin-B12 Level Lowers Risk of Parkinson’s Disease Dementia
- Novel Glycoprotein Biomarker Evaluated for Liver Fibrosis
- C-Reactive Protein Predicts Neurological Outcomes of Subarachnoid Hemorrhage Patients
- Germline Risk Variants Found in Prostate Cancer Patients
- Non-Invasive Blood Assay Can Detect Early Colorectal Cancer
- New Blood Test Can Determine When an Individual Was Exposed to a Pathogenic Microorganism
- Rare Kidney Cancer Marked by Molecular Features
- Higher Concentrations of COVID-19 Receptor Protein Found in Men’s Plasma
- Microcytosis Is a Risk Marker of Cancer in Primary Care
- Lupus Anticoagulant Prolongs Activated Partial-Thromboplastin Time in COVID-19
- Blood Clotting Causes Significant Mortality in COVID-19 Patients
- Physiological Mechanisms Underlying Prevalent Pediatric Leukemia Discovered
- Complete Blood Count Predicts Asymptomatic Preterm Birth
- A Series of Sensitive and Specific DNA-Based Assays Detects and Differentiates Salmonella Serotypes
- Giemsa Stain Outperforms Urease Test for Helicobacter Pylori Diagnosis
- Deep Throat SARS-CoV-2 Viral Load Ascertained in Saliva Samples
- Novel Rapid Test Developed for Detecting Carbapenemase
- Novel Nanofluidic Device Traps and Concentrates Pathogenic Bacteria
- Esophageal Cancer Precursor Detected by Electronic Nose Device
- Analyzer Platform for Simultaneous Detection of Multiple Sexually Transmitted Infections Is Now CE-marked
- New Chemistry Analyzer Completes Ortho Clinical Diagnostics’ Catalogue of VITROS XT Solutions
- Optical Biosensor Reduces Time for Sepsis Diagnosis
- Global Blood Glucose Monitoring Devices Market to Reach USD 13 Billion by 2023
- Global ELISA Kits Market to Surpass USD 418.5 Billion by 2025
- Thermo Fisher Scientific to Acquire QIAGEN N.V.
- New AI System Performs as Well as Expert Pathologists in Identifying Prostate Cancer
- Quest Diagnostics Acquires Blueprint Genetics
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- New Mount Sinai Venture to Manufacture and Distribute COVID Antibody Test Kits Globally
- Abbott Wins UK Government Contract to Supply Millions of Laboratory-Based IgG Antibody Tests
- Roche Acquires Stratos Genomics to Advance Development of DNA-Based Sequencing for Diagnostic Use
- GSK and Mammoth Biosciences to Jointly Develop Handheld, Disposable and Rapid CRISPR-based Test for COVID-19
- Enzo Biochem Launches Proprietary Test for Detection of Coronavirus SARS-CoV-2 IgG Antibody
Client Login